Nurse Practitioner, Family · Flowood, MS
NPI
1235436577
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
2510 Lakeland Dr
Flowood, MS, 39232
Phone (601) 355-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$74K
2,230 services
Medicare patients, 2024
671
Average age 72
Drug cost, 2024
$295K
716 prescriptions
Company payments, 2025
$1,049
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Quarles was code 99213 (office e&m - established), 665 times for 568 patients. In total David Quarles billed 2,230 services in 39 codes, and Medicare paid $74K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 665 | 568 | $47.49 | $32K |
| 76981 Ultrasound - Nonspecific | Office | 254 | 249 | $59.08 | $15K |
| 85025 Blood Count | Office | 209 | 165 | $7.56 | $1,579 |
| 80076 Clinical Chemistry | Office | 206 | 187 | $7.94 | $1,635 |
| 80053 Clinical Chemistry | Office | 189 | 144 | $10.22 | $1,933 |
| 76705 Ultrasound - Abdomen and Pelvis | Office | 145 | 112 | $35.70 | $5,177 |
| 91200 Standard X-ray | Office | 75 | 75 | $13.87 | $1,040 |
| 82105 Clinical Chemistry | Office | 74 | 61 | $16.43 | $1,216 |
| 99212 Office E&M - Established | Office | 67 | 60 | $28.80 | $1,930 |
| 99214 Office E&M - Established | Office | 53 | 52 | $71.13 | $3,770 |
| 82728 Clinical Chemistry | Office | 46 | 43 | $13.36 | $615 |
| 83540 Clinical Chemistry | Office | 46 | 43 | $6.34 | $292 |
| 84466 Clinical Chemistry | Office | 46 | 43 | $12.50 | $575 |
| 74177 CT/CTA - Abdomen and Pelvis | Office | 29 | 28 | $130.24 | $3,777 |
| 86708 Immunoassay | Office | 25 | 25 | $11.73 | $293 |
By year: 2022 $53K for 1,593 services; 2023 $82K for 2,194 services; 2024 $74K for 2,230 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 209 | 165 | $7.56 | $1,579 |
| 80076 Clinical Chemistry | 206 | 187 | $7.94 | $1,635 |
| 80053 Clinical Chemistry | 189 | 144 | $10.22 | $1,933 |
| 82105 Clinical Chemistry | 74 | 61 | $16.43 | $1,216 |
| 82728 Clinical Chemistry | 46 | 43 | $13.36 | $615 |
| 83540 Clinical Chemistry | 46 | 43 | $6.34 | $292 |
| 84466 Clinical Chemistry | 46 | 43 | $12.50 | $575 |
| 86708 Immunoassay | 25 | 25 | $11.73 | $293 |
| 80074 Clinical Chemistry | 24 | 23 | $46.68 | $1,120 |
| 82565 Clinical Chemistry | 11 | 11 | $5.02 | $55.22 |
Medicare prescription drug claims, 2024
In 2024, the drug David Quarles prescribed most often to Medicare patients was Famotidine, with 94 prescriptions and refills. In total David Quarles wrote 716 Medicare prescriptions that cost $295K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 94 | 247 | 43 | $1,078 |
| Omeprazole Generic | 65 | 143 | 25 | $494 |
| Pantoprazole Sodium Generic | 58 | 130 | 24 | $493 |
| Sucralfate Generic | 47 | 52 | 31 | $1,827 |
| Rezdiffra Resmetirom | 46 | 46 | Under 11 | $180K |
| Dicyclomine Hcl Generic | 42 | 50 | 30 | $621 |
| Colesevelam Hcl Generic | 30 | 49 | 18 | $3,795 |
| Metronidazole Generic | 30 | 30 | 30 | $238 |
| Ursodiol Generic | 28 | 37 | Under 11 | $2,018 |
| Ondansetron Odt Ondansetron | 26 | 26 | 25 | $881 |
| Ciprofloxacin Hcl Generic | 23 | 23 | 23 | $161 |
| Spironolactone Generic | 20 | 30 | Under 11 | $125 |
| Furosemide Generic | 14 | 14 | Under 11 | $19.2 |
| Linzess Linaclotide | 12 | 16 | Under 11 | $8,097 |
| Lactulose Generic | 11 | 15 | Under 11 | $647 |
Brand drugs: 141 claims; generic drugs: 575 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Quarles $1,049 ($1,049 in general payments such as food, travel and fees) from 14 companies. The largest payer was Madrigal Pharmaceuticals with $356.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 11 | $356 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 6 | $179 |
| Abbvie Inc. ABBV | 4 | $151 |
| Phathom Pharmaceuticals, Inc. PHAT | 9 | $102 |
| Fujifilm Healthcare Americas Corporation | 1 | $47.04 |
| Novo Nordisk Inc NVO | 2 | $34.32 |
| Ardelyx, Inc. ARDX | 1 | $31.64 |
| QOL Medical, LLC | 1 | $22.88 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $22.39 |
| Aimmune Therapeutics, Inc. | 1 | $22.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.